Chitosan microparticles for the controlled delivery of fluoride

被引:58
|
作者
Keegan, Gemma M. [2 ]
Smart, John D. [1 ]
Ingram, Matthew J. [1 ]
Barnes, Lara-Marie [1 ]
Burnett, Gary R. [3 ]
Rees, Gareth D. [1 ,4 ]
机构
[1] Brighton Univ, Sch Pharm & Biomol Sci, Brighton BN2 4GJ, E Sussex, England
[2] Chiesi Ltd, Chippenham SN14 0AB, Wilts, England
[3] GlaxoSmithKline Consumer Healthcare, Weybridge KT13 0DE, Surrey, England
[4] Genesis Oral Biosci, Horley RH6 7AN, Surrey, England
基金
英国生物技术与生命科学研究理事会;
关键词
Chitosan; Microparticles; Bioadhesion; Fluoride; Controlled release; CONTROLLED-RELEASE; STREPTOCOCCUS-MUTANS; MICROSPHERES; ENAMEL; TABLETS; CARIES; SALIVA; MUCOADHESION; DENTIFRICE; RETENTION;
D O I
10.1016/j.jdent.2011.12.012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives: To manufacture and characterise chitosan/fluoride microparticles prepared by spray drying and assess their utility as controlled release vehicles for fluoride. Methods: Microparticles were manufactured from dispersions containing 1.0% and 2.0% (w/v) chitosan and 0.20% or 0.40% (w/v) NaF in the absence/presence of glutaraldehyde. Particle size distributions were determined using laser diffraction; fluoride loading and release were determined by ion-selective electrode. Release profiles were studied in isotonic media (pH 5.5) over 360 min; microparticles exhibiting greatest cumulative fluoride release were further evaluated at pH 4.0 and 7.0. Particle morphology was investigated using environmental scanning electron microscopy. Bioadhesion parameters were determined with a texture-probe analyser. Results: Microparticles exhibited low polydispersity and volume mean diameters (VMDs) < 6 mu m. VMDs increased on doubling the chitosan/fluoride concentrations but were largely independent of glutaraldehyde concentration. Recovered yields were inversely proportional to dispersion viscosity due to compromised fluid atomisation; adding NaF reduced viscosity and improved yields. Best-case entrapment efficiency and NaF loading were 84.1% and 14%, respectively. Release profiles were biphasic, releasing 40-60% of the total fluoride during the first 600 s, followed by a prolonged release phase extending out to 6 h. Incorporation of 0.40% NaF to the 2.0% chitosan dispersion yielded microparticles with reduced bioadhesive parameters (F-max and WOA) versus the chitosan-only control whilst retaining significant bioadhesive potential. Conclusions: Bioadhesive chitosan/fluoride microparticles manufactured using a spray-drying protocol have been extensively characterised and further opportunity for optimisation identified. These microparticles may provide a means of increasing fluoride uptake from oral care products to provide increased protection against caries, however further work is required to demonstrate this principle in vivo. Clinical significance: Spray-drying is a low-cost route for the manufacture of bioadhesive chitosan/fluoride microparticles which can be exploited as controlled fluoride release agents to aid fluoride retention in the oral cavity. The potential exists to optimise release profiles to suit the delivery format thereby maximising the cariostatic benefits. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:229 / 240
页数:12
相关论文
共 50 条
  • [1] Preparation and characterization of chitosan microparticles intended for controlled drug delivery
    Ko, JA
    Park, HJ
    Hwang, SJ
    Park, JB
    Lee, JS
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 249 (1-2) : 165 - 174
  • [2] Chitosan Spray-Dried Microparticles for Controlled Delivery of Venlafaxine Hydrochloride
    Aranaz, Inmaculada
    Panos, Ines
    Peniche, Carlos
    Heras, Angeles
    Acosta, Niuris
    [J]. MOLECULES, 2017, 22 (11):
  • [3] Chelators influenced synthesis of chitosan–carboxymethyl cellulose microparticles for controlled drug delivery
    Antony V. Samrot
    Tatipamula Akanksha
    S. Jahnavi
    Sheryl-Ann Padmanaban
    Ujjala Philip
    Arul Maximus Burman
    [J]. Applied Nanoscience, 2016, 6 : 1219 - 1231
  • [4] Development of new chitosan-cellulose multicore microparticles for controlled drug delivery
    Remunan-Lopez, C
    Lorenzo-Lamosa, ML
    Vila-Jato, JL
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1998, 45 (01) : 49 - 56
  • [5] Chitosan microparticles for delivery of proteins to the retina
    Wassmer, Sarah
    Rafat, Mehrdad
    Fong, Wai Gin
    Baker, Adam N.
    Tsilfidis, Catherine
    [J]. ACTA BIOMATERIALIA, 2013, 9 (08) : 7855 - 7864
  • [6] Chelators influenced synthesis of chitosan-carboxymethyl cellulose microparticles for controlled drug delivery
    Samrot, Antony V.
    Akanksha
    Jahnavi, Tatipamula
    Padmanaban, S.
    Philip, Sheryl-Ann
    Burman, Ujjala
    Rabel, Arul Maximus
    [J]. APPLIED NANOSCIENCE, 2016, 6 (08) : 1219 - 1231
  • [7] Fabrication of casein-chitosan microparticles of curcumin for controlled delivery - Physico-chemical characterization
    [J]. Roopa, G. (roopa.gg@gmail.com), 1600, Bentham Science Publishers (09):
  • [8] Microfluidic synthesis of chitosan-coated magnetic alginate microparticles for controlled and sustained drug delivery
    Yang, Dong
    Gao, Keyi
    Bai, Yang
    Lei, Lei
    Jia, Tongtong
    Yang, Kaidi
    Xue, Chaohua
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2021, 182 : 639 - 647
  • [9] Controlled insulin release from chitosan microparticles
    Bugamelli, F
    Raggi, MA
    Orienti, I
    Zecchi, V
    [J]. ARCHIV DER PHARMAZIE, 1998, 331 (04) : 133 - 138
  • [10] Biodegradable microparticles for the controlled delivery of oligonucleotides
    De Rosa, G
    Quaglia, F
    La Rotonda, MI
    Besnard, M
    Fattal, E
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 242 (1-2) : 225 - 228